The latest price target for Vivani Medical (NASDAQ:VANI) was reported by HC Wainwright & Co. on April 16, 2025. The analyst firm set a price target for $4.00 expecting VANI to rise to within 12 months (a possible 280.95% upside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Vivani Medical (NASDAQ:VANI) was provided by HC Wainwright & Co., and Vivani Medical reiterated their buy rating.

There is no last upgrade for Vivani Medical

There is no last downgrade for Vivani Medical.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vivani Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vivani Medical was filed on April 16, 2025 so you should expect the next rating to be made available sometime around April 16, 2026.

While ratings are subjective and will change, the latest Vivani Medical (VANI) rating was a reiterated with a price target of $4.00 to $4.00. The current price Vivani Medical (VANI) is trading at is $1.05, which is out of the analyst’s predicted range.